Skip to main content
NIH funding notice PA-18-076

Prescription Drug Abuse (R21 Clinical Trial Optional)

Closed on May 7, 2019.

Posted
November 2, 2017
Close date
May 7, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $769,818 in first-year total cost, median $259,465.

Most frequent study sections

  1. Addiction Risks and Mechanisms Study Section[ARM]1
  2. Community Influences on Health Behavior Study Section[CIHB]1
  3. Molecular Neuropharmacology and Signaling Study Section[MNPS]1

Most frequent institutions

  1. MCLEAN HOSPITAL2
  2. RAND CORPORATION1
Competing awards under PA-18-076 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Prenatal oxycodone exposure: developmental effects on microglia and addiction-like behavior in rats1R21DA048399-01CHARTOFF, ELENA HMCLEAN HOSPITAL, MA$264,353MNPS
2019Can Mandatory Electronic Prescriptions Reduce Opioid Abuse?1R21DA045983-01A1ABOUK, RAHIPOWELL, DAVIDRAND CORPORATION, CA$259,465CIHB
2019Implicit and Explicit Suicidal Cognition and Risk for Opioid Overdose1R21DA046521-01A1MCHUGH, REBECCA KATHRYNMCLEAN HOSPITAL, MA$246,000ARM

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-18-076: Prescription Drug Abuse (R21 Clinical Trial Optional) | ScienceDex | ConductScience